Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 12th 2024 | Updated: October 6th 2024
D-VRd Boosts MRD Negativity in Transplant-Eligible Multiple Myeloma
Published: July 18th 2024 | Updated: October 6th 2024
NCCN Guidelines Revisions and ASCO 2024 Research Outlook
Published: October 2nd 2024 | Updated: October 6th 2024
Isatuximab Approval Highlights Role of Anti-CD38 Antibody in Myeloma Care
Published: October 2nd 2024 | Updated: October 6th 2024
Coming Soon: An Off-the-Shelf CAR T Therapy for Myeloma